View Filing Data

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
Mar. 31, 2010	Dec. 31, 2009
Current assets:
Cash and cash equivalents	$ 172.2	$ 148.5
Accounts receivable, net of allowance for doubtful accounts of $169.9 and $173.1 at March 31, 2010 and December 31, 2009, respectively	614.3	574.2
Supplies inventories	82.5	90.0
Prepaid expenses and other	74.3	80.1
Deferred income taxes	37.7	42.8
Total current assets	981.0	935.6
Property, plant and equipment, net	488.4	500.8
Goodwill, net	1,911.1	1,897.1
Intangible assets, net	1,382.1	1,342.2
Investments in joint venture partnerships	69.2	71.4
Other assets, net	102.4	90.7
Total assets	4,934.2	4,837.8
Current liabilities:
Accounts payable	169.3	183.1
Accrued expenses and other	347.1	275.7
Noncontrolling interest	0.0	142.4
Short-term borrowings and current portion of long-term debt	370.0	417.2
Total current liabilities	886.4	1,018.4
Long-term debt, less current portion	958.3	977.2
Deferred income taxes and other tax liabilities	604.0	577.7
Noncontrolling interest	145.6	0.0
Other liabilities	161.3	158.4
Total liabilities	$ 2,755.6	$ 2,731.7
Commitments and contingent liabilities
Noncontrolling interest	$ 20.2	$ 0.0
Shareholders' equity
Common stock, 104.2 and 105.3 shares outstanding at March 31, 2010 and December 31, 2009, respectively	12.4	12.5
Additional paid-in capital	0.0	36.7
Retained earnings	3,002.7	2,927.9
Less common stock held in treasury	(934.9)	(932.5)
Accumulated other comprehensive income	78.2	61.5
Total shareholders' equity	2,158.4	2,106.1
Total liabilities and shareholders' equity	$ 4,934.2	$ 4,837.8

EARNINGS PER SHARE	3 Months Ended
EARNINGS PER SHARE	Mar. 31, 2010
Notes To Financial Statements [Abstract]
EARNINGS PER SHARE	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"2.#160;#160;EARNINGS PER SHARE/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Basic earnings per share is computed by dividing net earnings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company#8217;s outstanding stock options, restricted stock awards, performance share awards, and shares issuable upon conversion of zero-coupon subordinated notes./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The following represents a reconciliation of basic earnings per share to diluted earnings per share:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inl ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three months ended/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SI ZE: 10pt; FONT-FAMILY: times new roman"Three months ended/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31, 2010/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bo ttom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31, 2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom" ;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM ILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Per Share/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Per Share/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"# 160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Income/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim es new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Shares/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Amount/font/di v/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Income/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim es new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Shares/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Amount/font/di v/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Basic earnings per share:/font/div/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA MILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td ;td valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td style="PADDING-BOTTOM: 4px" valign="bottom" width="28%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Net earnings/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt ; FONT-FAMILY: times new roman"$/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"132.7/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"104.6/font/ tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.27/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font /tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"132.8/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"108.1/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPL AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.23/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="28%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Dilutive effect of employee/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd s tyle="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti mes new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10p t; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" w idth="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="28%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;#160;#160;#160;stock options and awards/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right " valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="28%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Effect of convertible debt,/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" mp;#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"fon t style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"div style="DISPLAY: block; MARGIN-LE FT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;#160;#160;#160;net of tax/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FON T-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.1/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" gt;#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td gt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.1/font/td t;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="whit e"td valign="bottom" width="28%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Diluted earnings per share:/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="botto m" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td t;td style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMI LY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="28%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Net earnings including impact/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign=" bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" #160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FO NT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white" lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="28%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;#160;#160;#160;of dilutive adjustments/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"132.7/font/tdtd style="PADDING-BOTTOM: 4px; TEX T-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"106.5/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTO M: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.25/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: l eft" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"132.8/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: rig ht" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"108.8/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.22/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"#160;/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" #160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three Months Ended/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORD ER-BOTTOM: black 2px solid" valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31,/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td gt;/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Stock options/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdt d valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"4.0/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div

GOODWILL AND INTANGIBLE ASSETS	3 Months Ended
GOODWILL AND INTANGIBLE ASSETS	Mar. 31, 2010
Notes To Financial Statements [Abstract]
GOODWILL AND INTANGIBLE ASSETS	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"8.#160;#160;GOODWILL AND INTANGIBLE ASSETS/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The changes in the carrying amount of goodwill for the three-month period ended March 31, 2010 and for the year ended December 31, 2009 are as follows:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspa cing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31,/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; T EXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31,/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div gt;/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt ; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Balance as of January 1/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1,897.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#1 60;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1,772.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Goodwill acquired during the period/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" #160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"14.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 1 0pt; FONT-FAMILY: times new roman"124.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Adjustments to goodwill/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BO RDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.1/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.8/font/tdtd style="PADDING-BOTTOM : 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="76%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; F ONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman"Balance at end of period/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1,911.1/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 1 0pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1,897.1/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"#160;/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The components of ident ifiable intangible assets are as follows:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31, 2010/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="n owrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31, 2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Gross/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font gt;/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Gross/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; F ONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Carrying/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style=" DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Accumulated/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Carrying/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Accumulated/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Amount/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Amortization/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Amount/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Amortization/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT - -FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Customer relationships/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%" t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"827.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(334.6/font/tdtd style="TEXT-ALIGN: left" valign="bot tom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"839.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(337.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td/trtr bgcolor="white"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Patents, licenses and technology/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign ="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"144.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(65.7/font/td td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"119.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/fon t/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(62.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Non-compete agreements/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font lt;/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"15.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(5.9/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"39.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-F AMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(30.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td/trtr bgcolor="white"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Trade name/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom an"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"117.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT - -SIZE: 10pt; FONT-FAMILY: times new roman"(43.9/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"117.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLA Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(41.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td/trtr bgcolor="#cceeff"td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Canadian licenses/font/div/tdtd style="PADDING-BOTTOM: 2px" valign= "bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"727.9/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" val ign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" v align="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"698.1/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="52%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160 ;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new r oman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style ="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1,832.2/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(450.1/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 1 0pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1,814.2/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 1 0pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(472.0/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Amortization of intangible assets for the three month periods ended March 31, 2010 and 2009 was $17.4 and $15.1, respectively. Amortization expense for the net carrying amount of intangible ass ets is estimated to be $51.5 for the remainder of fiscal 2010, $64.2 in fiscal 2011, $59.7 in fiscal 2012, $56.7 in fiscal 2013, $53.9 in fiscal 2014 and $368.2 thereafter./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Ontario operation had $727.9 and $698.1 of value assigned to the partnership#8217;s indefinite lived Canadian licenses to conduct diagnostic testing services in the province as of March 31, 2010 and December 31, 2009, respectively./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div

DEBT

3 Months Ended

Mar. 31, 2010

Notes To Financial Statements [Abstract]

DEBT

9. DEBT

Short-term borrowings and the current portion of long-term debt at March 31, 2010 and December 31, 2009 consisted of the following:

	March 31,		December 31,
	2010		2009
Zero-coupon convertible subordinated notes	$	293.7	$	292.2
Term loan, current		56.3		50.0
Revolving credit facility		20.0		75.0
Total short-term borrowings and current portion
of long-term debt	$	370.0	$	417.2

Long-term debt at March 31, 2010 and December 31, 2009 consisted of the following:

March 31,

PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY	3 Months Ended
PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY	Mar. 31, 2010
Notes To Financial Statements [Abstract]
PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"10. PREFERRED STOCK AND COMMON SHAREHOLDERS#8217; EQUITY/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company#8217;s treasury shares are recorded at aggregate cost. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of March 31, 2010./font ;/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The changes in common shares issued and held in treasury are summarized below:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10 pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Held in/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan ="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Issued/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIG N: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Treasury/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Outstanding/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="64%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Common shares at December 31, 2009/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"127.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(22.1/font t;/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"105.3/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="64%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; T EXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Common stock issued under employee stock plans/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti mes new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Retirement of common stock/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td ;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(1.5/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style ="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(1.5/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td/tr t;tr bgcolor="white"td valign="bottom" width="64%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/ font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT - -FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Common shares at March 31, 2010/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style= "BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"126.3/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(22.1/font/tdtd sty le="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"104.2/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr gt;/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Share Repurchase Program/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;As of December 31, 2009, the Company had outstanding authorization from the Board of Directors to purchase approximately $71.8 of Company common stock. On February 11, 2010, the Board of Directors authorized the purchase of $250.0 of additional shares of the Company#8217;s common stock. During the three months ended March 31, 2010, the Compa ny purchased approximately 1.5 shares of its common stock at a total cost of approximately $105.7.#160;As of March 31, 2010, the Company had outstanding authorization from the Board of Directors to purchase approximately $216.1 of Company common stock./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div

INCOME TAXES	3 Months Ended
INCOME TAXES	Mar. 31, 2010
Notes To Financial Statements [Abstract]
INCOME TAXES	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"11. INCOME TAXES/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company does not recognize a tax benefit, unless the Company concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position. If the recognition threshold is met, the Company recognizes a tax benefit measured at the largest amount of the tax benefit that the Company believes is grea ter than 50% likely to be realized./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The gross unrecognized income tax benefits were $61.5 and $59.0 at March 31, 2010 and December 31, 2009, respectively. It is anticipated that the amount of the unrecognized income tax benefits will change within the next twelve months; however, these changes are not expected to have a significant impact on the results of operations, cash flows or the financial position of the Company./font/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"#160;/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"fo nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;As of March 31, 2010 and December 31, 2009, $62.8 and $60.3, respectively, is the approximate amount of unrecognized income tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods./font/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"#160;/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company recognizes interest and penalties related to unrecognized income tax benefits in income tax expense. Accrued interest and penalties related to uncertain tax positions totaled $13.6 and $14.7 as of March 31, 2010 and December 31, 2009, respectively./font /divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;During the first quarter of 2010, the Company closed its 2006 Internal Revenue Service examination. As a result, the Company has substantially concluded all U.S. federal income tax matters for years through 2006. Substantially all material state and local, and foreign income tax matters have been concluded through 2004 and 2001, respectively./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company has va rious state income tax examinations ongoing throughout the year. Management believes adequate provisions have been recorded related to all open tax years./font/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"br //div

COMMITMENTS AND CONTINGENCIES	3 Months Ended
COMMITMENTS AND CONTINGENCIES	Mar. 31, 2010
Notes To Financial Statements [Abstract]
COMMITMENTS AND CONTINGENCIES	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"12. COMMITMENTS AND CONTINGENCIES/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company was a party in a patent case originally filed by Competitive Technologies, Inc. and Metabolite Laboratories, Inc. in the United States District Court for the District of Colorado. After a jury trial, the district court entered judgment against the Company for patent infringement, with total damages and attorney#8217;s fees payable by the Company o f approximately $7.8. The underlying judgment has been paid. The Company vigorously contested the judgment and appealed the case ultimately to the United States Supreme Court. On June 22, 2006, the Supreme Court dismissed the Company#8217;s appeal and the case was remanded to the District Court for further proceedings, including resolution of a related declaratory judgment action initiated by the Company addressing the plaintiffs#8217; claims for post trial damages. On August 15, 2008, the District Court entered judgment in favor of the Company on all of the plaintiffs#8217; remaining claims. Metabolite Laboratories, Inc. filed an appeal to the Federal Circuit. After briefing and oral argument, the#160;Federal Circuit determined that it did not have jurisdiction over the appeal. Accordingly, the Federal Circuit issued a decision transferring the appeal to the Tenth Circuit.#160;The Company does not expect the resolution of these issues to have a material adverse effect on its financi al position, results of operations or liquidity./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;A subsidiary of the Company, DIANON Systems, Inc. (#8220;DIANON#8221;), is the appellant in a wrongful termination lawsuit originally filed by G. Berry Schumann in Superior Court in the State of Connecticut.#160;#160;After a jury trial, the state court entered judgment against DIANON, with total damages, attorney#8217;s fees, and pre-judgment interest payable by DIANON, of approximately $10.0. DIANON filed a notice of appeal in December 2009 and is awaiting a briefing schedule. DIANON has disputed liability and intends to contest the case vigorously on appeal./font/divdiv style="DISPL AY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation, arising in the ordinary course of business. Some of these actions involve claims that are substantial in amount. These matters include, but are not limited to, intellectual property disputes, professional liability, employee related matters, and inquiries, including subpoenas and other civil investigative demands, from governmental agencies and Medicare or Medicaid payers and managed care payers reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. The Company receives c ivil investigative demands or other inquiries from various governmental bodies in the ordinary course of its business. Such inquiries can relate to the Company or other healthcare providers. The Company works cooperatively to respond to appropriate requests for information./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;As previously reported on May 22, 2006, the Company received a subpoena from the California Attorney General seeking documents related to billing to the state#8217;s Medicaid program. The Company subsequently reported during the third quarter of 2008, that it received a request from the California Attorney General for additional information. On March 20, 2009, a qui tam lawsuit, font style="DISPLAY : inline; FONT-STYLE: italic"California ex rel. Hunter Laboratories, LLC et al. v. Quest Diagnostics Incorporated, et al./font, which was joined by the California Attorney General and to which the previous subpoena related, was unsealed. The lawsuit was brought against the Company and several other major laboratories operating in California and alleges that the defendants improperly billed the state Medicaid program. The Company's motion to dismiss the original complaint on the basis of (i) misjoinder and (ii) lack of particularity in the Fifth Amended /fontfont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Complaint was successful. As a result, the California Attorney General and qui tam relator filed a separate amended complaint against the Company on December 14, 2009. The Company filed an answer to the new Complaint on February 5, 2010./font/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="j ustify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"/font#160;/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;During 2009, the Company received subpoenas from two state agencies requesting documents related to its billing to Medicaid in those states. The Company also responded to subpoenas from the United States Office of Inspector General#8217;s regional offices in New York and Massachusetts regarding certain of its billing practices. The Company is cooperating with the requests./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times N ew Roman"#160;#160;#160;#160;#160;The Company is also named from time to time in suits brought under the qui tam provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from federal or state health care programs. They may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the qui tam plaintiff. Such claims are an inevitable part of doing business in the health care field today./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Several of these matters are in their early stages of develop ment and management cannot predict the outcome of such matters. In the opinion of management, the ultimate disposition of such matters is not expected to have a material adverse effect on the financial position of the Company but may be material to the Company#8217;s results of operations or cash flows in the period in which such matters are finally determined or resolved./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company believes that it is in compliance in all material respects with all statutes, regulations and other requirements applicable to its clinical laboratory operations. The clinical laboratory testing industry is, however, subject to extensive regulation, and the courts have not interpreted many o f these statutes and regulations. There can be no assurance therefore that those applicable statutes and regulations will not be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant fines and the loss of various licenses, certificates and authorizations./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;During the fourth quarter of 2008, the Company recorded a $7.5 cumulative revenue adjustment relating to certain historic overpayments made by Medicare for claims submitted by a subsidiary of the Company. The Company has forwarded a detailed claims file and refund p ayment to the Medicare carrier. No additional requests for information have been received from the carrier./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Effective January 1, 2007, the Company commenced its successful implementation of its ten-year agreement with United Healthcare Insurance Company (#8220;UnitedHealthcare#8221;) and became its exclusive national laboratory provider. During the first three years of the ten-year agreement, the Company committed to reimburse UnitedHealthcare up to $200.0 for transition costs related to developing expanded networks in defined markets during the first three years of the agreement. Since the inception of this agreement, approximately $118.8 of such transition payments were billed to the Company by UnitedHealthcare and approximately $117.3 had been remitted by the Company. Based on the trend rates of the transition payment amounts billed by UnitedHealthcare during the three months of 2010 and for 2009, 2008 and 2007, the Company believes that its total reimbursement commitment under this agreement will be approximately $125.6 and that the final invoices for these payments will be processed during the second quarter of 2010. The Company is amortizing the total estimated transition costs over the life of the contract./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Under the Company#8217;s present insurance programs, coverage is obtained for catastrophic exposure as well as those risk s required to be insured by law or contract. The Company is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers#8217; compensation. The self-insured retentions are on a per occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company#8217;s estimates of the aggregated liability of claims incurred. At March 31, 2010, the Company had provided letters of credit aggregating approximately $39.1, primarily in connection with certain insurance programs. The Company#8217;s availability under its Revolving Facility is reduced by the amount of these letters of credit./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"#160;/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"#160;#160;#160;#160; /fontAt March 31, 2010, the Company was a guarantor on approximately $2.5 of equipment leases. These leases were entered into by a joint venture in which the Company owns a 50% interest and have a remaining term of approximately three years./font/div/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"#160;/div

PENSION AND POSTRETIREMENT PLANS	3 Months Ended
PENSION AND POSTRETIREMENT PLANS	Mar. 31, 2010
Notes To Financial Statements [Abstract]
PENSION AND POSTRETIREMENT PLANS	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"13. PENSION AND POSTRETIREMENT PLANS/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;In October 2009, the Company received approval from its Board of Directors to freeze any additional service-based credits for any years of service after December 31, 2009 on the defined benefit retirement plan (the #8220;Company Plan#8221;) and the non-qualified supplemental retirement plan (the #8220;PEP#8221;). Both plans have be en closed to new participants. Employees participating in the Company Plan and the PEP no longer earn service-based credits, but continue to earn interest credits. In addition, effective January 1, 2010, all employees eligible for the defined contribution retirement plan (the #8220;401K Plan#8221;) receive a minimum 3% non-elective contribution (#8220;NEC#8221;) concurrent with each payroll period. The NEC replaces the Company match, which has been discontinued. Employees are not required to make a contribution to the 401K Plan to receive the NEC. The NEC is non-forfeitable and vests immediately. The 401K Plan also permits discretionary contributions by the Company#160;of 1% to 3% of pay for eligible employees based on service./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT- FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company believes these changes to the Company Plan, the PEP and its 401K plan align the Company#8217;s retirement plan strategy with prevailing industry practices and reduce the impact of market volatility on the Company Plan./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;As a result of the changes to the Company Plan and PEP, projected pension expense for the Company Plan and the PEP will decrease from $36.6 in 2009 to $10.4 in 2010. In addition, the Company does not plan to make contributions to the Company Plan during 2010. The implementation of the NEC will increase the Company#8217;s 401K costs and contributions by an estimate d $22.5 in 2010./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-WEIGHT: bold"#160;#160;#160;#160;#160;/fontThe effect on operations for the Company Plan and the PEP is summarized as follows:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/fo nt/tdtd valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three Months Ended/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center" t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31,/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div/tdtd style="PADDIN G-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Service cost for benefits earned/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td t;td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"5.2/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Interest cost on benefit obligation/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td ;td style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"4.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" 4.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Expected return on plan assets/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n ew roman"(4.7/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(4.3/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td/trtr bgcolor="white"td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Net amortization and deferral/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.0/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.1/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="76%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#1 60; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Defined benefit plan costs/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.6/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bott om" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"8.6/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company assumed obligations under a subsidiary#8217;s post-retirement medical plan. Coverage under this plan is restricted to a limited number of existing employees of the subsidiary. This plan is unfunded and the Company#8217;s policy is to fund benefits as claims are incurred. The effect on operations of the po st-retirement medical plan is shown in the following table:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three Months Ended/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" amp;#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31,/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT - -SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style= "DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Service cost for benefits earned/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-F AMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inl ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Interest cost on benefit obligation/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style=" DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font st yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Net amortization and deferral/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.2/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style= "DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.4/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td/trtr bgcolor="white"td valign="bottom" width="76%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY : inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Post-retirement medical plan costs/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font ;/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.5/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.3/font/td t;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"#160;/div

FAIR VALUE MEASUREMENTS	3 Months Ended
FAIR VALUE MEASUREMENTS	Mar. 31, 2010
Notes To Financial Statements [Abstract]
FAIR VALUE MEASUREMENTS	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -35.8pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"14. FAIR VALUE MEASUREMENTS/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company#8217;s population of financial assets and liabilities subject to fair value measurements as of March 31, 2010 and December 31, 2009 are as follows:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Fair value/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN - -RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Fair Value Measurements as of/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"as of/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DIS PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31, 2010/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro man"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31,/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Using Fair Value Hierarchy/font ;/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE : 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 1/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DI SPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 2/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 3/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-S IZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="now rap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Noncontrolling interest puts/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"165.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width= "1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width ="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"165.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign=" bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="52%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" amp;#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim es new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"fo nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Derivatives/font/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style ="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; t;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; F ONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Embedded derivatives related to the zero-coupon subordinated notes/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font s tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%" lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="botto m" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Interest rate swap liability/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"9.5/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim es new roman"--/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"9.5/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IND ENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Total fair value of derivatives/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"9.5/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" mp;#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td ;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"9.5/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BO RDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MAR GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Fair value/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Fair Value Measurements as of/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr lt;td valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"as of/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center" lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31, 2009/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31,/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT - -ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="10"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Using Fair Value Hierarchy/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" #160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IN DENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 1/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 2/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman "#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 3/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font /tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style ="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Noncontrolling interest put/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"142.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-S IZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"142.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font s tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="52%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom" width="1% "font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style=" TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"fo nt style="DISPLAY: inline; TEXT-DECORATION: underline"Derivatives/font/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bot tom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td ;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Embedded derivatives related to the zero-coupon subordinated notes/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td style="PADDIN G-BOTTOM: 2px" valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Interest rate swap liability/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.6/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: in line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT- FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.6/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Total fair value of derivatives/font/div/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti mes new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.6/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" t;10.6/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" #160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The noncontrolling interest puts are valued at their contractually determined values, which approximate fair values. The fair values for the embedded derivatives and interest rate swap are based on observable inputs or quoted market prices from various banks for similar instruments./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the zero-coupon subordinated notes, based on market pricing, was approximately $374.4 and $374.6 as of March 31, 2010 and December 31, 2009, respectively. The fair market value of the senior notes, based on market pricing, was approximately $642.1 and $645.2 as of March 31, 2010 and December 31, 2009, respectively. As of March 31, 2010 and December 31, 2009, the estimated fair market value of the Company#8217;s variable rate debt of $422.4 and $486.4, respectively, was estimated by calculating the net present value of related cash flows, discounted at current market rates./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	3 Months Ended
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	Mar. 31, 2010
Notes To Financial Statements [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"15. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments such as interest rate swap agreements (see Interest Rate Swap section below). Although the Company#8217;s zero-coupon subordinated notes contain features that are considered to be embedded derivative instruments (see Embedded Derivative section below), the Company does not hold or issue derivative financial instruments for trading purposes. The Company does not believe that its exposure to market risk is material to the Company#8217;s financial position or results of operations./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Interest Rate Swap/font/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: in line; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company has an interest rate swap agreement with a remaining term of approximately two years to hedge variable interest rate risk on the Company#8217;s variable interest rate term loan. On a quarterly basis /fontfont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"under the swap, the Company pays a fixed rate of interest (2.92%) and receives a variable rate of interest based on the three-month LIBOR rate on an amortizing notional amount of indebtedness equivalent to the term loan balance outstanding. The swap has been designated as a cash flow hedge. Accordingly, the Company recognizes the fair value of the swap in the condensed consolidated balance sheets and any changes in the fair value are recorded as adjustments to accumulated other comprehensive income (loss), net of tax. The fair value of the interest rate swap agreement is the estimated amount that t he Company would pay or receive to terminate the swap agreement at the reporting date. The fair value of the swap was a liability of $9.5 and $10.6 at March 31, 2010 and December 31, 2009, respectively, and is included in other liabilities in the condensed consolidated balance sheets./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Embedded Derivatives Related to the Zero-Coupon Subordinated Notes/font/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#1 60;#160;#160;#160;The Company#8217;s zero-coupon subordinated notes contain the following two features that are considered to be embedded derivative instruments under authoritative guidance in connection with accounting for derivative instruments and hedging activities:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdivtable style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="top" width="3%"div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1)/fontfont style="COLOR: black; LETTER-SPACING: 9pt"#160;/font/div/tdtd valign="top" width="74%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"The Company will pay contingent cash interest on the zero-coupon subordinated notes after September 11, 2006, if the average market price of the notes equals 120% or more of the sum of the issue price, accrued original issue discount and contingent additional principal, if any, for a specified measurement period./font/div/td/trtrtd valign="top" width="3%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="top" width="74%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td/trtrtd valign="top" width="3%"div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2)/fontfont style="COLOR: black; LETTER-SPACING: 9pt"#160;/font/div/tdtd valign="top" width="74% "div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Holders may surrender zero-coupon subordinated notes for conversion during any period in which the rating assigned to the zero-coupon subordinated notes by Standard amp; Poor#8217;s Ratings Services is BB- or lower./font/div/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The Company believes these embedded derivatives had no fair value at March 31, 2010 and December 31, 2009. These embedded derivatives also had no impact on the condensed consolidated statements of operations for the th ree months ended March 31, 2010 and 2009./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The following table summarizes the fair value and presentation in the consolidated balance sheets for derivatives designated as hedging instruments (interest rate swap liability derivative) as of March 31, 2010 and December 31, 2009, respectively:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; lt;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Fair Value as of/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31,/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31,/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" p;#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline"Balance Sheet Location/font/div/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" gt;#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Other liabilities/font/div ;/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"9.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/t dtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The following table summarizes the effect of the interest rate swap on other comprehensive income for the three months ended March 31, 2010 and 2009:/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SI ZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DIS PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Effective portion of derivative gain/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE : 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY : inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div

SUPPLEMENTAL CASH FLOW INFORMATION	3 Months Ended
SUPPLEMENTAL CASH FLOW INFORMATION	Mar. 31, 2010
Notes To Financial Statements [Abstract]
SUPPLEMENTAL CASH FLOW INFORMATION	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"16. SUPPLEMENTAL CASH FLOW INFORMATION/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv align="left"table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"trtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three Months Ended/font/div/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"March 31,/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="b ottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="PADDING-BOTTOM: 2px" valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div/tdtd style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2" font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtrtd valign="bottom"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -35.8pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Suppl emental schedule of cash flow information:/font/div/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/ font/td/trtrtd valign="bottom"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -35.8pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Cash paid during period for:/font/div/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" colspan="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" col span="2"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;#160;#160;#160;Interest/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td gt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13.5/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"14.1/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro man"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;#160;#160;#160;Income taxes, net of refunds/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" wid th="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"7.6/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -35.8pt" align="justify"font s tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Disclosure of non-cash financing and investing activities:/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/ tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="#cceeff"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -35.8pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Accrued repurchases of common stock/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FON T-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"5.4/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="D ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td/trtr bgcolor="white"td valign="bottom" width="76%"div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -35.8pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;#160;#160;#160;#160;Purchase of equipment in accrued expenses/font/div/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd st yle="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"--/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: left" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/tdtd style="TEXT-ALIGN: right" valign="bottom" width="9%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.8/font/tdtd style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" t;#160;/font/td/tr/table/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div

Entity Information - USD ($)	3 Months Ended
Entity Information - USD ($)	Mar. 31, 2010	Apr. 22, 2010	Jun. 30, 2009
Entity Registrant Name	LABORATORY CORP OF AMERICA HOLDINGS
Entity Central Index Key	0000920148
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 7,400,000,000
Entity Common Stock, Shares Outstanding		104,000,000
Document Fiscal Year Focus	2010
Document Fiscal Period Focus	Q1

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2010	Mar. 31, 2009
Income Statement [Abstract]
Net sales	$ 1,193.6	$ 1,155.7
Cost of sales	686.7	666.3
Gross profit	506.9	489.4
Selling, general and administrative expenses	246.0	233.8
Amortization of intangibles and other assets	17.4	15.1
Restructuring and other special charges	9.3	0.0
Operating income	234.2	240.5
Other income (expenses):
Interest expense	(14.6)	(17.0)
Income from joint venture partnerships, net	3.8	2.8
Investment income	0.3	0.4
Other, net	(0.6)	(0.5)
Earnings before income taxes	223.1	226.2
Provision for income taxes	86.9	90.4
Net earnings	136.2	135.8
Less: Net earnings attributable to the noncontrolling interest	(3.5)	(3.0)
Net earnings attributable to Laboratory Corporation of America Holdings	$ 132.7	$ 132.8
Basic earnings per common share	$ 1.27	$ 1.23
Diluted earnings per common share	$ 1.25	$ 1.22

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2010	Mar. 31, 2009
Statement [Line Items]
BALANCE	$ 2,106.1	$ 1,688.3
Comprehensive earnings:
Net earnings attributable to Laboratory Corporation of America Holdings	132.7	132.8
Other comprehensive earnings:
Foreign currency translation adjustments	25.5	(21.1)
Interest rate swap adjustments	1.1	0.4
Tax effect of other comprehensive earnings adjustments	(9.9)	7.8
Comprehensive earnings	149.4	119.9
Issuance of common stock under employee stock plans	18.1	5.7
Surrender of restricted stock awards	(2.4)	(2.7)
Stock compensation	8.7	7.2
Value of noncontrolling interest put	(17.2)
Income tax benefit adjustments related to stock options exercised	1.4	(0.4)
Purchase of common stock	(105.7)
BALANCE	2,158.4	1,818.0
Common Stock
Statement [Line Items]
BALANCE	12.5	12.8
Comprehensive earnings:
Net earnings attributable to Laboratory Corporation of America Holdings	0.0	0.0
Other comprehensive earnings:
Foreign currency translation adjustments	0.0	0.0
Interest rate swap adjustments	0.0	0.0
Tax effect of other comprehensive earnings adjustments	0.0	0.0
Issuance of common stock under employee stock plans	0.0	0.0
Surrender of restricted stock awards	0.0	0.0
Stock compensation	0.0	0.0
Value of noncontrolling interest put	0.0
Income tax benefit adjustments related to stock options exercised	0.0	0.0
Purchase of common stock	(0.1)
BALANCE	12.4	12.8
Additional Paid-in Capital
Statement [Line Items]
BALANCE	36.7	237.4
Comprehensive earnings:
Net earnings attributable to Laboratory Corporation of America Holdings	0.0	0.0
Other comprehensive earnings:
Foreign currency translation adjustments	0.0	0.0
Interest rate swap adjustments	0.0	0.0
Tax effect of other comprehensive earnings adjustments	0.0	0.0
Issuance of common stock under employee stock plans	18.1	5.7
Surrender of restricted stock awards	0.0	0.0
Stock compensation	8.7	7.2
Value of noncontrolling interest put	(17.2)
Income tax benefit adjustments related to stock options exercised	1.4	(0.4)
Purchase of common stock	(47.7)
BALANCE	0.0	249.9
Retained Earnings
Statement [Line Items]
BALANCE	2,927.9	2,384.6
Comprehensive earnings:
Net earnings attributable to Laboratory Corporation of America Holdings	132.7	132.8
Other comprehensive earnings:
Foreign currency translation adjustments	0.0	0.0
Interest rate swap adjustments	0.0	0.0
Tax effect of other comprehensive earnings adjustments	0.0	0.0
Issuance of common stock under employee stock plans	0.0	0.0
Surrender of restricted stock awards	0.0	0.0
Stock compensation	0.0	0.0
Value of noncontrolling interest put	0.0
Income tax benefit adjustments related to stock options exercised	0.0	0.0
Purchase of common stock	(57.9)
BALANCE	3,002.7	2,517.4
Treasury Stock
Statement [Line Items]
BALANCE	(932.5)	(929.8)
Comprehensive earnings:
Net earnings attributable to Laboratory Corporation of America Holdings	0.0	0.0
Other comprehensive earnings:
Foreign currency translation adjustments	0.0	0.0
Interest rate swap adjustments	0.0	0.0
Tax effect of other comprehensive earnings adjustments	0.0	0.0
Issuance of common stock under employee stock plans	0.0	0.0
Surrender of restricted stock awards	(2.4)	(2.7)
Stock compensation	0.0	0.0
Value of noncontrolling interest put	0.0
Income tax benefit adjustments related to stock options exercised	0.0	0.0
Purchase of common stock	0.0
BALANCE	(934.9)	(932.5)
Accumulated Other Comprehensive (Loss) Income
Statement [Line Items]
BALANCE	61.5	(16.7)
Comprehensive earnings:
Net earnings attributable to Laboratory Corporation of America Holdings	0.0	0.0
Other comprehensive earnings:
Foreign currency translation adjustments	25.5	(21.1)
Interest rate swap adjustments	1.1	0.4
Tax effect of other comprehensive earnings adjustments	(9.9)	7.8
Issuance of common stock under employee stock plans	0.0	0.0
Surrender of restricted stock awards	0.0	0.0
Stock compensation	0.0	0.0
Value of noncontrolling interest put	0.0
Income tax benefit adjustments related to stock options exercised	0.0	0.0
Purchase of common stock	0.0
BALANCE	$ 78.2	$ (29.6)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2010	Mar. 31, 2009
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$ 136.2	$ 135.8
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	50.0	47.3
Stock compensation	8.7	7.2
Loss on sale of assets	0.5	0.3
Accreted interest on zero-coupon subordinated notes	1.5	2.8
Cumulative earnings less than distribution from joint venture partnerships	0.4	0.6
Deferred income taxes	10.0	10.3
Change in assets and liabilities (net of effects of acquisitions):
Increase in accounts receivable (net)	(38.4)	(38.4)
Decrease in inventories	7.7	7.7
Decrease in prepaid expenses and other	5.0	13.7
Increase (decrease) in accounts payable	(14.8)	15.1
Increase in accrued expenses and other	65.2	6.5
Net cash provided by operating activities	232.0	208.9
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(24.5)	(30.7)
Proceeds from sale of assets	1.6	0.0
Deferred payments on acquisitions	(1.4)	(0.4)
Investment in equity affiliate	0.0	(4.3)
Acquisition of businesses, net of cash acquired	(32.2)	(5.9)
Net cash used for investing activities	(56.5)	(41.3)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities	65.0	0.0
Payments on revolving credit facilities	(120.0)	0.0
Principal payments on term loan	(12.5)	(12.5)
Payments on vendor-financed equipment	(1.3)	0.0
Decrease in bank overdraft	0.0	(3.9)
Proceeds from sale of interest in consolidated subsidiary	137.5	0.0
Cash paid to acquire an interest in a consolidated subsidiary	(137.5)	0.0
Noncontrolling interest distributions	(2.8)	(2.0)
Tax benefit adjustments related to stock based compensation	0.9	(0.4)
Net proceeds from issuance of stock to employees	18.1	5.7
Purchase of common stock	(100.3)	0.0
Net cash used for financing activities	(152.9)	(13.1)
Effect of exchange rate changes on cash and cash equivalents	1.1	(1.0)
Net increase in cash and cash equivalents	23.7	153.5
Cash and cash equivalents at beginning of period	148.5	219.7
Cash and cash equivalents at end of period	$ 172.2	$ 373.2

BASIS OF FINANCIAL STATEMENT PRESENTATION	3 Months Ended
BASIS OF FINANCIAL STATEMENT PRESENTATION	Mar. 31, 2010
Notes To Financial Statements [Abstract]
BASIS OF FINANCIAL STATEMENT PRESENTATION	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"1.#160;#160;BASIS OF FINANCIAL STATEMENT PRESENTATION/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The consolidated financial statements include the accounts of Laboratory Corporation of America Holdings (the #8220;Company#8221;) and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant infl uence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20% and no representation on the investee#8217;s board of directors) are accounted for using the cost method. All significant inter-company transactions and accounts have been eliminated. The Company does not have any variable interest entities or special purpose entities whose financial results are not included in the condensed consolidated financial statements./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The financial statements of the Company#8217;s foreign subsidiaries are measured using the loca l currency as the functional currency. Assets and liabilities are translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average monthly exchange rates prevailing during the period. Resulting translation adjustments are included in #8220;Accumulated other comprehensive income.#8221;/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The accompanying condensed consolidated financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results a re not necessarily indicative of results for a full year. The year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by generally accepted accounting principles./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;The financial statements and notes are presented in accordance with the rules and regulations of the Securities and Exchange Commission and do not contain certain information included in the Company#8217;s 2009 annual report on Form 10-K. Therefore, the interim statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company#8217;s annual report./font t;/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"#160;/div

NEW ACCOUNTING PRONOUNCEMENTS	3 Months Ended
NEW ACCOUNTING PRONOUNCEMENTS	Mar. 31, 2010
Notes To Financial Statements [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"3. NEW ACCOUNTING PRONOUNCEMENTS/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-SIZE: 10pt"#160;#160;#160;#160;#160;/fontIn June 2009, the FASB issued authoritative guidance in connection with adding qualified special purpose entities into the scope of guidance for consolidation of variable interest entities. This literature also modifies the analysis by which a controlling interest of a variable interest entity is determined thereby requiring the controlling interest to consolidate the variable interest entity. A controlling interest exists if a party to a variable interest entity has both (i) the power to direct the activities of a variable interest entity that most significantly impact the entity#8217;s economic performance and (ii) the obligation to absorb losses of or receive benefits from the entity that could be potentially significant to the variable interest entity. The guidance became effective in the first quarter of 2010. The adoption of the authoritative guidance did not have an impact on the Company#8217;s consolidated financial statements as of and for the three months ended March 31, 2010./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div

PARENTHETICAL DATA TO THE CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Mar. 31, 2010	Dec. 31, 2009
Current assets:
Allowance for doubtful accounts	$ 169.9	$ 173.1
Shareholders' equity
Common stock, shares outstanding (in shares)	104.2	105.3

BUSINESS ACQUISITIONS	3 Months Ended
BUSINESS ACQUISITIONS	Mar. 31, 2010
Notes To Financial Statements [Abstract]
BUSINESS ACQUISITIONS	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"4. BUSINESS ACQUISITIONS/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;During the three months ended March 31 2010, the Company acquired various laboratories and related assets for approximately $32.2 in cash (net of cash acquired). These acquisitions were made primarily to enhance the Company#8217;s scientific differentiation and esoteric testing capabilities./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br / gt;/divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Monogram Biosciences, Inc. (acquired by the Company in August 2009) has an active research and development department, which is primarily focused on the development of oncology and infectious disease technology. As a result of this acquisition, the Company incurred approximately $3.4 of research and development expenses (included in selling, general and administrative expenses) for the three months ended March 31, 2010./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div

NONCONTROLLING INTEREST PUT	3 Months Ended
NONCONTROLLING INTEREST PUT	Mar. 31, 2010
Notes To Financial Statements [Abstract]
NONCONTROLLING INTEREST PUT	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"5.#160;#160;NONCONTROLLING INTEREST PUT/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Effective January 1, 2008 the Company acquired additional partnership units in its Ontario, Canada (#8220;Ontario#8221;) joint venture, bringing the Company#8217;s percentage interest owned to 85.6%. Concurrent with this acquisition, the terms of the joint venture#8217;s partnership agreement were amended. The amended joint venture#82 17;s partnership agreement enables the holders of the noncontrolling interest to put the remaining partnership units to the Company in defined future periods, at an initial amount equal to the consideration paid by the Company in 2008, and subject to adjustment based on market value formulas contained in the agreement./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;In December 2009, the Company received notification from the holders of the noncontrolling interest in the Ontario joint venture that they intended to put their remaining partnership units to the Company in accordance with the terms of the joint venture#8217;s partnership agreement. These units were acquired on February 8, 2010 for $137.5. On February 17, 2 010, the Company completed a transaction to sell the units acquired from the previous noncontrolling interest holder to a new Canadian partner for the same price. As a result of this transaction, the Company recorded a component of noncontrolling interest in other liabilities and a component in mezzanine equity. Upon the completion of these two transactions, the Company#8217;s financial ownership percentage in the joint venture partnership remained unchanged at 85.6%. Concurrent with the sale to the new partner, the partnership agreement for the Ontario joint venture was amended and restated with substantially the same terms as the previous agreement. The combined contractual value of these puts, in excess of the current noncontrolling interest of $24.8, totals $141.0 at March 31, 2010./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style= "DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;Net sales of the Ontario joint venture were $68.9 (CN$71.7) and $55.6 (CN$69.2) for the three months ended March 31, 2010 and 2009, respectively./font/divbr /

RESTRUCTURING AND OTHER SPECIAL CHARGES	3 Months Ended
RESTRUCTURING AND OTHER SPECIAL CHARGES	Mar. 31, 2010
Notes To Financial Statements [Abstract]
RESTRUCTURING AND OTHER SPECIAL CHARGES	div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"6.#160;#160;RESTRUCTURING AND OTHER SPECIAL CHARGES/font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //divdiv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"#160;#160;#160;#160;#160;During the first quarter of 2010, the Company recorded net restructuring charges of $3.1 related to severance payments and the closing of redundant and underutilized facilities. Of this amount, $3.9 related to severance and other employee costs for employees primarily in the affected facilities, and $0.6 related to contractual obligati ons associated with leased facilities and other facility related costs. The Company also reduced its prior facility related restructuring accruals by $1.4 as a result of incurring less cost than planned on those restructuring initiatives primarily due to favorable settlements on lease buyouts. In addition, the Company recorded a special charge of $6.2 related to the write-off of development costs incurred on systems abandoned during the quarter./font/divdiv style="DISPLAY: block; TEXT-INDENT: 0pt"br //div